NCT04962711View on ClinicalTrials.gov

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

NARecruitingINTERVENTIONAL
Enrollment

685

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Heart Failure
Interventions
OTHER

Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP)

A clinical review to ensure optimal risk factor control and cardioprotection along with exercise intervention.

OTHER

Usual care

provided by participants' usual healthcare professional(s)

Trial Locations (1)

3004

RECRUITING

Baker Heart and Diabetes Institute, Melbourne

All Listed Sponsors
lead

Baker Heart and Diabetes Institute

OTHER